Post by
TheRock07 on Apr 05, 2016 6:08pm
37 million shares bought today at 11 cents
Approximately 14 million of those were acquired by the selling house, probably intra house transfers to its other clients .
Cash value here is about $50 million or about 16 cents per share.
An update on the FDA meeting is expected very shortly.
As I said earlier, the clinical trial results seem to be very good with high probability of life extension with a very good safety profile.
What I expect is that the FDA will recommend some minor tests such that efficacy measures and survival induces cf with conventional are clearly defined and incremental.
The market seems to be saying the same thing.
Trading below cash and on the cusp of final approval of a world class drug, such news would see the share price reach former highs
Comment by
HighteawithIntrepid on Apr 05, 2016 6:46pm
I can get to 30 million but having trouble beyond that. Care to share your math?
Comment by
TheRock07 on Apr 05, 2016 7:06pm
This post has been removed in accordance with Community Policy